Recursion Pharmaceuticals, Inc.
- Last sale
- Nov 12, 2026 · -7.39%
- Market cap
- $2.07B
- 622.76M shares
- Filings
- 993
Q3 2026+26.9% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+25.1% FY25 yoy
- $2.07B
- —
- 30.3×
- 2.3×
- -15.11%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $74,681,000 | reported | |
| FY 2024 | 2024-12-31 | $58,839,000 | reported | |
| FY 2023 | 2023-12-31 | $44,575,000 | reported | |
| FY 2022 | 2022-12-31 | $39,843,000 | reported | |
| FY 2021 | 2021-12-31 | $10,178,000 | reported | |
| FY 2020 | 2020-12-31 | $3,962,000 | reported | |
| FY 2019 | 2019-12-31 | $2,319,000 | reported |
Segments
LineFY2025ShareChange
United States$39.34M53%−31.4%
United Kingdom$35.34M47%+3,013.4%
Other$0.00—−100.0%
Total$74.68M
Biological products, except diagnostic substances
Recursion Pharmaceuticals, Inc. is the 35th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
FDMT4D Molecular Therapeutics, Inc.$85.2M230,194.6%164.4%$682.1MMGTXMeiraGTx Holdings plc$81.4M144.6%140.3%$858.1MAUTLAutolus Therapeutics plc$75.4M644.9%381.4%$318.3M
RXRXRecursion Pharmaceuticals, Inc. (this company)$74.7M26.9%863.4%$2.1B
CLLSCellectis S.A.$72.9M75.8%92.7%—CGENCompugen Ltd$72.8M161.1%48.6%$200.5MBDTXBlack Diamond Therapeutics, Inc.$70.0M—32.0%$86.8MVIRVir Biotechnology, Inc.$68.6M7.6%638.9%$2.1BCSBRChampions Oncology, Inc.$59.4M4.4%2.0%$76.4MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Recursion Pharmaceuticals, Inc. · CIK 1601830 · Engraved from SEC EDGAR